A
ABBioUK
InactiveThe startup develops complex p53 antibodies that target a range of diseases, including oncology and Alzheimer's, providing researchers and pharmaceutical companies with specific drug targets for therapeutic applications. This technology addresses the need for effective treatments by enabling precise targeting of disease mechanisms at the molecular level.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops complex p53 antibodies that target a range of diseases, including oncology and Alzheimer's, providing researchers and pharmaceutical companies with specific drug targets for therapeutic applications. This technology addresses the need for effective treatments by enabling precise targeting of disease mechanisms at the molecular level.